Informing payers and patients of biological therapy advantages can strengthen biosimilars market Read more
Neovascularization inhibitor sales will near $7 bn in diabetic retinopathy market in 2029: GlobalData Read more
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData Read more
67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData Read more
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData Read more
COVID-19 vaccines need novel approaches to ensure best balance of safety and efficacy: GlobalData Read more